1. Home
  2. ENOV vs PENN Comparison

ENOV vs PENN Comparison

Compare ENOV & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • PENN
  • Stock Information
  • Founded
  • ENOV 1995
  • PENN 1972
  • Country
  • ENOV United States
  • PENN United States
  • Employees
  • ENOV N/A
  • PENN N/A
  • Industry
  • ENOV Fluid Controls
  • PENN Hotels/Resorts
  • Sector
  • ENOV Industrials
  • PENN Consumer Discretionary
  • Exchange
  • ENOV Nasdaq
  • PENN Nasdaq
  • Market Cap
  • ENOV 2.1B
  • PENN 2.3B
  • IPO Year
  • ENOV 2008
  • PENN 1994
  • Fundamental
  • Price
  • ENOV $30.11
  • PENN $17.05
  • Analyst Decision
  • ENOV Strong Buy
  • PENN Buy
  • Analyst Count
  • ENOV 5
  • PENN 19
  • Target Price
  • ENOV $58.00
  • PENN $23.03
  • AVG Volume (30 Days)
  • ENOV 1.3M
  • PENN 4.3M
  • Earning Date
  • ENOV 08-06-2025
  • PENN 08-07-2025
  • Dividend Yield
  • ENOV N/A
  • PENN N/A
  • EPS Growth
  • ENOV N/A
  • PENN N/A
  • EPS
  • ENOV N/A
  • PENN N/A
  • Revenue
  • ENOV $2,150,191,000.00
  • PENN $6,643,700,000.00
  • Revenue This Year
  • ENOV $8.23
  • PENN $7.93
  • Revenue Next Year
  • ENOV $6.18
  • PENN $5.59
  • P/E Ratio
  • ENOV N/A
  • PENN N/A
  • Revenue Growth
  • ENOV 18.32
  • PENN 5.51
  • 52 Week Low
  • ENOV $29.13
  • PENN $13.25
  • 52 Week High
  • ENOV $49.83
  • PENN $23.08
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 38.02
  • PENN 60.16
  • Support Level
  • ENOV $31.48
  • PENN $15.58
  • Resistance Level
  • ENOV $32.61
  • PENN $16.77
  • Average True Range (ATR)
  • ENOV 1.11
  • PENN 0.62
  • MACD
  • ENOV -0.11
  • PENN 0.15
  • Stochastic Oscillator
  • ENOV 20.12
  • PENN 82.68

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About PENN PENN Entertainment Inc.

Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.

Share on Social Networks: